On March 9, speaking about the company's development strategy, Zhou Jing, secretary to the board of Directors and chief financial officer of Chen Guang Biotech Group, said that the company has developed a three-step stratrgy.
The first step is to become the world's first capsanthin production and sales, to achieve IPO, this step has been achieved, and continue to expand the advantages.
The second step is to make ten of the world's first or forefront of the product, the construction of the world's natural plant extract industry base, which is gradually realized.
The third step is to expand and strengthen the great health industry, such as the extraction of health food products and Traditional Chinese medicine, and make contributions to human health. This is the company's medium - and long-term goal, which is being accelerated in the layout at present.
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
